Target intelligence / Profile preview

Bacterial nucleoside transporter

Molecular classification
Transporter, Solute carrier family
01

Overview

Bacterial nucleoside transporters are specialized membrane proteins that facilitate the uptake of nucleosides and nucleobases from the extracellular environment into the bacterial cytoplasm (Patching et al., 2005). These transporters, which include the NupC and NupG families in Escherichia coli and other Gram-negative bacteria, are essential for the nucleotide salvage pathway, allowing the cell to recycle preformed genetic precursors instead of relying on de novo synthesis (Young et al., 2013). By scavenging host-derived nucleosides, these systems support bacterial metabolism and replication during infection. In the context of pharmacology, these transporters are exploited as entry points for nucleoside-based antimetabolites and "Trojan horse" antibiotics, which mimic natural substrates to gain access to the cell and inhibit DNA or RNA polymerase (Mulligan et al., 2014). For example, analogs like 5-fluorouridine utilize these pathways to exert bactericidal effects. A major challenge in targeting these proteins is the structural conservation between bacterial transporters and human Equilibrative (ENT) or Concentrative (CNT) nucleoside transporters, which can lead to off-target effects and host toxicity (Paproski et al., 2013).

Other names
Nucleoside permeaseNucleoside-proton symporterNupCNupGPnuCTsx proteinBacterial nucleoside uptake system
02

Mechanism of action

Facilitated transport or active symport of nucleoside analogs into the bacterial cell to disrupt nucleic acid synthesis or metabolic pathways.

03

Biological functions

Nucleoside uptakeNucleotide salvage pathwayNutrient acquisitionMetabolic homeostasis
04

Disease associations

Infection
05

Safety considerations

Potential cross-reactivity with human Equilibrative Nucleoside Transporters (ENTs) and Concentrative Nucleoside Transporters (CNTs)Risk of host mitochondrial toxicityDevelopment of bacterial resistance through transporter downregulation or mutation
06

Interacting drugs

5-Fluorouridine

5 more in the full profile.

07

Biomarkers

Bacterial transporter expression levelsPathogen-specific nucleoside uptake rates

Beyond the preview

Go deeper on Bacterial nucleoside transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial nucleoside transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call